Mg. Murray et al., INACTIVATION OF A YEAST TRANSACTIVATOR BY THE FUSED HIV-1 PROTEINASE - A SIMPLE ASSAY FOR INHIBITORS OF THE VIRAL ENZYME-ACTIVITY, Gene, 134(1), 1993, pp. 123-128
The human immunodeficiency virus type 1 (HIV-1) proteinase (PR) and it
s flanking sequences have been fused in frame between the DNA-binding
domain and the transcription-activation domain of the yeast protein, G
AL4. As has been shown before with the 3C proteinase of Coxsackie viru
s B3 (CVB3) [Das Mahapatra et al., Proc. Natl. Acad. Sci. USA 89 (1992
) 4159-4162], the GAL4::PR fusion protein retains its GAL4 function, p
roviding the PR is inactive. When PR is active, its autocatalytic acti
vity in the hybrid protein is shown to inactivate the transactivation
function of GAL4. This provides a simple assay to monitor PR activity.
A dose-dependent effect of a potent PR-specific inhibitor is demonstr
ated in this system and illustrates the sensitivity of the assay. The
assay is used for high throughput screening to identify novel inhibito
rs of the viral PR, and provides a method to generate and analyze muta
nts and revertants of the PR.